This is a question we get asked
regularly! As a general rule - if you are developing a biomedical
technology the answer will be yes, BUT, you can verify this for yourself! There is a searchable database of science award
information from 17 federal funding agencies, including NIH, FDA, CDC, and
NSF. The database (Federal RePORTER) is updated annually and
includes information for ~900,000 projects. NIH
has also developed the NIH RePORTER database which includes a “Matchmaker” tab. If you enter your specific
aims or project summary you will find similar projects that have been
funded by the NIH, which institutes funded those projects, which study sections
reviewed them, and potential collaborators or SBIR/STTR-funded
companies in your subject or geographic area to ask for advice.
NIH is updating application forms to FORMS-E for
due dates of Jan 25, 2018 and beyond. FORMS-E includes a brand new form. Check
it out using the resources below.
For more information, please read the full Notice: NOT-OD-17-062
Extended deadline: October 27, 2017, 5:00PM ET
Submit proposals through eCPS
website
The National Heart, Lung, and Blood Institute invites small business concerns to submit research proposals under the Small Business Innovation Research (SBIR) Contract Solicitation. Firms with the capability to conduct research and development (R&D) in any of the health-related topic areas below and to commercialize the results of that R&D, are encouraged to participate.
- Devices for Transcatheter Surgery
- Tapered Guidewires for Transcatheter Electrosurgery
- Reagent Development for Small Cell Number ChIC-seq
A Question & Answer
Amendment has been published with the purpose of responding to questions
submitted by interested parties to gain better understanding of the 2017
NIH/CDC SBIR Contract Solicitation: Q&A Amendment 2
If you missed the August 15,
2017 webinar on PHS 2018-1 solicitation, check it out: Webinar Slides
For more information on how to apply, please read the full Notice: NOT-OD-17-089
19th Annual HHS SBIR/STTR Conference
November 7 - 9, Milwaukee, Wisconsin
Register HERE
This conference is relevant to a diverse audience, including biomedical entrepreneurs; principal investigators; grants and contracts administrators; and industry partners and investors.
Top 3 Reasons to Attend:
1. Meet one-on-one with HHS SBIR/STTR program managers
Over 100 federal staff, including representatives from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Small Business Administration (SBA), Administration for Community Living (ACL), and HHS Office of the Inspector General (OIG) will be holding one-on-one meetings and giving presentations. You will have the chance to get one-on-one feedback about your technology proposal!
2. Hear from successful HHS SBIR/STTR awardees
Gain first-hand knowledge from experienced and successful applicants, potential funding partners and companies during interactive workshops and sessions. These sessions include a diverse group of successful awardees, including women-owned small businesses and socially and economically disadvantaged small businesses.
3. Learn how to develop a competitive application
Many sessions focus on how to develop and submit your SBIR/STTR application. Topics include:
- How to submit your SBIR/STTR grant proposal electronically via ASSIST
- FDA regulatory requirements for drugs and devices
- Important considerations to protect your intellectual property
- Top 10 Dos and Don’ts for SBIR/STTR proposal development
- Understanding indirect costs and financial accounting systems
- What you need to know about human subjects and animal research
- The differences between SBIR grants and contracts
4. NHLBI SBIR/STTR experts from Office of
Translational Alliances and Coordination will present
OTAC’s Chris Sasiela:
- “FDA Regulatory Basics for Small Businesses” on Tuesday afternoon
and Wednesday morning.
OTAC’s Gary Robinson:
- “NIH Resources for Small Businesses” on Tuesday afternoon.
-
“Writing Your Phase II Commercialization Plan” on Wednesday and
Thursday afternoon.
For more information, please visit Clinical &
Translational Science Institute
Application
due date: December 8, 2017
The United States Patent & Trademark
Office recently announced their Patents for
Humanity competition, which recognizes innovators who use game-changing technology to
meet global humanitarian challenges. Winners are publicly recognized and
receive an acceleration certificate to expedite select USPTO proceedings.
Visit the USPTO's
Patents for Humanity website for more information and how to apply
Download the application
HERE
Are you as jazzed as we are to know that FDA is willing to share the
way they think about product development with you? Are you wondering if there is a guidance document you should know about?
You can easily search the FDA
Guidance database to find out if the FDA has a formal opinion on any aspect of
your technology development.
On Tuesday, FDA released three new guidance documents that
may be of interest to our medical device community:
10/31 - 2017 NIH Innovation
Conference - New York, NY
11/1 - 11/2 - Life Sciences Summit - New York, NY
11/7 - 11/9 - 19th
Annual HHS SBIR/STTR Conference - Milwaukee, WI
11/13 – 11/15 – NSF Workshop on Organizational Issues
in Technology Transfer at Federal Laboratories –
Phoenix, AZ
11/14 – Partnering for Cures –
San Francisco, CA
01/08 – 01/10 – Biotech Showcase –
San Francisco, CA
01/09 – Redefining
Early Stage Investments (RESI) - San Francisco, CA
01/10 – 13th
Annual Non-Dilutive Funding Summit - San Francisco, CA
02/18 – 02/21 - AUTM 2018 – Phoenix,
AZ
03/03 – 03/06 – CRT 2018 – Washington, DC
|